Finance outlook india logo
Home News Exclusive Expert's Viewpoint Corporate Startup Fintech Personal Magazine Round Up 2025 Budget'24
  • Budget'25 Budget'24
    • Home
    • News
    Tata Chemicals Shares to Trade Ex-dividend Today

    Tata Chemicals Shares to Trade Ex-dividend Today


    Finance Outlook India Team | Wednesday, 12 June 2024

     

    When the stock market opens on Wednesday, June 12, Tata Chemicals Ltd shares will be the focus.

    Tata Chemicals' Board of Directors announced a final dividend of ₹15.00 per equity share for the fiscal year 2024 to eligible shareholders. The corporation had set June 12 as the record date to determine shareholders' eligibility for the last dividend.

    Ex-dividend Date

    Tata Chemicals Ltd shares will trade ex-dividend on Wednesday, June 12. Tata Chemicals Ltd shares closed Tuesday at ₹1,111.50, up ₹25.15 or 2.32 percent on the BSE.

    In a report with the stock exchange, Tata Chemicals stated: "The Board of Directors had, at its meeting held on Monday, April 29, 2024, recommended a dividend of ₹15 per ordinary share of Rs10 each, subject to approval by the shareholders of the Company at the 85th AGM."

    "According to Regulation 42 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the Company has designated Wednesday, June 12, 2024 as the Record Date for determining Members' entitlement to dividends for the fiscal year ending March 31, 2024. The dividend, if declared by the Members at the next AGM, will be paid on or after Friday, June 28, 2024, subject to tax deduction at source," according to the filing.

    Q4 earnings

    Tata Chemicals Ltd recorded a net loss of ₹818 crore in the fourth quarter of fiscal year 2024, down from a profit of ₹694 crore the previous year.

    The company recorded a Q4 loss of ₹963 crore due to decreased income and a provision for extraordinary events in the UK division.

    In the reporting quarter, the company's consolidated profit after tax (excluding extraordinary items and non-controlling interest) from continuing operations was ₹145 crore, down from ₹694 crore in the same period last year.

    In the fourth quarter of the previous fiscal year, Tata Chemicals' overall income declined to ₹3,589 crore from ₹4,482 crore the year before.

    In fiscal year 2024, the company's profit after tax decreased by 82% to ₹449 crore from continuing operations. This was primarily owing to a loss of ₹861 crore from extraordinary items and decreased income.



    Read More:

    Piyush Goyal Announces Rs 10,000 Crore Fund of Funds for Startups

    Ashika Institutional, MOFSL & Bajaj Broking Markets Closing Commentary

    KNOWLEDGE DECK

    Most Viewed

    • The Economic Impact of India-Pakistan War: A Detailed Analysis

    • Why Financial Literacy Matters More Than Ever for Today's Youth

    • Prominent Financial Advisors in India to Partner With

    • Rags to Riches: The Top 6 Indian Entrepreneurs' Motivational Tales of Success

    • Navigating Financial Disruption With Future Proof Financial Service Deliverability

    • India's Rs 31 Lakh Cr Green Push: Building the Foundation of a Net-Zero Future

    • Wakhariya & Wakhariya: Facilitating International Legal Processes across Diverse Domains

    • Aligning Financial Strategies with Sustainable Business Goals

    • The Top 5 Highest-paid Actors in India - 2024

    • Central Government Proposes Tax on Agricultural Water Usage

    • Carpediem Capital Invests INR 100 Crore, CorporatEdge to Deploy INR 350 Crore in the next 3 Years

    • EPFO Registers All-Time High Member Addition of 20.06 Lakh in May 2025

    • Unearthing Intricacies of Today and Beyond in the Indian Insurance Sector

    • Expected Correction in Housing Prices to Revive Sales in Coming Quarters

    • How to Choose the Right Mutual Fund for your Financial Goals?

    • Future of Corporate Finance: Emerging Trends in Treasury Solutions and Cash Management for MNCs

    • ElasticRun Announces FY24 Financial Results: Key Details

    • Financial Inclusion in Viksit Bharat

    • Abans Financial Services Advises Vaishali Pharma on Strategic Acquisition of Kesar Pharma






    🍪 Do you like Cookies?

    We use cookies to ensure you get the best experience on our website. Read more...

    Copyright © 2026 Finance Outlook India. All rights reserved.   Privacy Policy Terms of Use Blogs Conferences Subscribe About Us